The Tests When every patient is different and every tumor is unique, MammaPrint and BluePrint can provide the genomic information needed to personalize breast cancer care.

The Kit

MammaPrint and BluePrint tests are now available in an FFPE kit format to be run on the Illumina® MiSeq® Next Generation Sequencing Platform.

The MammaPrint BluePrint Kit is for in vitro diagnostic use.

Contact an Agendia Customer Service representative for select regional availability outside the U.S.